{"entity":{"type":"insider","cik":"0001846045","url":"/insider/0001846045","json_url":"/insider/0001846045.json","name":"Vieser Jaime","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":4,"first":"2021-10-04","last":"2025-01-03","span_basis":"filed_date"},"name_variants":[{"name":"Vieser Jaime","source":"filing","n_filings":4,"first_seen":"2021-10-04","last_seen":"2025-01-03"}],"transactions":[{"id":4832122,"accession":"0000950170-25-001257","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-001257","line_url":"/filing/0000950170-25-001257","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"Alaunos Therapeutics, Inc.","issuer_ticker":"TCRT","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001846045","owner_name":"Vieser Jaime","owner_display_name":"Vieser Jaime","owner_url":"/insider/0001846045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":2.0072733333333335,"price_display":"2.01","price_state":"stated","total_value":6021.82,"total_display":"6,021.82","total_whole":"6,022","shares_owned_after":26712.0,"shares_owned_after_display":"26,712","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-31","filed_date":"2025-01-03","scope":"insider","n_lines":2},{"id":2436782,"accession":"0001213900-24-109470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-24-109470","line_url":"/filing/0001213900-24-109470#line-1","is_derivative":false,"issuer_cik":"0001846045","issuer_name":"Mountain Lake Acquisition Corp.","issuer_ticker":"MLAC","issuer_name_source":null,"issuer_url":"/issuer/0001846045","owner_cik":"0001846045","owner_name":"Vieser Jaime","owner_display_name":"Vieser Jaime","owner_url":"/insider/0001846045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Ordinary Share, par value $0.0001 per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":null,"price_display":null,"price_state":"not-stated","total_value":null,"total_display":null,"total_whole":null,"shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-12-16","filed_date":"2024-12-16","scope":"insider"},{"id":6510263,"accession":"0000899243-22-037274","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-037274","line_url":"/filing/0000899243-22-037274#line-1","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"Alaunos Therapeutics, Inc.","issuer_ticker":"TCRT","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001846045","owner_name":"Vieser Jaime","owner_display_name":"Vieser Jaime","owner_url":"/insider/0001846045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1250000.0,"shares_display":"1,250,000","price_per_share":0.65,"price_display":"0.65","price_state":"stated","total_value":812500.0,"total_display":"812,500.00","total_whole":"812,500","shares_owned_after":1250000.0,"shares_owned_after_display":"1,250,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-11-29","filed_date":"2022-12-01","scope":"insider"},{"id":4902774,"accession":"0001209191-21-059131","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-059131","line_url":"/filing/0001209191-21-059131#line-1","is_derivative":false,"issuer_cik":"0001107421","issuer_name":"ZIOPHARM ONCOLOGY INC","issuer_ticker":"ZIOP","issuer_name_source":null,"issuer_url":"/issuer/0001107421","owner_cik":"0001846045","owner_name":"Vieser Jaime","owner_display_name":"Vieser Jaime","owner_url":"/insider/0001846045","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":1.91,"price_display":"1.91","price_state":"stated","total_value":191000.0,"total_display":"191,000.00","total_whole":"191,000","shares_owned_after":705321.0,"shares_owned_after_display":"705,321","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-29","filed_date":"2021-10-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001107421","name":"Alaunos Therapeutics, Inc.","url":"/issuer/0001107421","role":"Director","n_filings":3,"first_seen":"2021-10-04","last_seen":"2025-01-03"},{"type":"issuer","type_label":"ISSUER","cik":"0002029492","name":"Mountain Lake Acquisition Corp.","url":"/issuer/0002029492","role":"Director","n_filings":1,"first_seen":"2024-12-16","last_seen":"2024-12-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001846045","retrieved_at":"2026-08-22T15:23:00+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}